98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/gutjnl-2022-327799 | DOI Listing |
J Healthc Sci Humanit
January 2024
Bioethics Honors Student.
Efforts to reduce the unequal impacts and generations of systemic disadvantage and inequality in healthcare for black and brown communities became amplified and were made more urgent during the COVID-19 pandemic. Moreover, public health surveillance systems have been challenged to address the vulnerabilities that residents within these environments and experiences. This paper describes the methodology used to develop a public health ethics and bioethics surveillance system grounded in empathy and care ethics.
View Article and Find Full Text PDFJ Healthc Sci Humanit
January 2024
Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.
Introduction: COVID-19 infects minority groups with comorbidities at higher rates than whites. In addition, children are at risk of vaccine hesitancy based on parents' acceptance and due to disparity. About twenty percent of workers would get vaccinated, especially if required by work.
View Article and Find Full Text PDFJ Healthc Sci Humanit
January 2024
University of Texas Health, Austin Pediatric Neurosciences at Dell Children's Hospital, 512-628-1855.
The study investigates the potential impact of COVID-19 vaccines on menstrual cycles, with a particular focus on Black women and those with underlying reproductive health conditions. Despite numerous reports of menstrual irregularities post-vaccination, research on this subject remains limited. The study aims to explore whether these irregular cycles could indicate broader reproductive health concerns, such as reduced ovarian reserve, and whether certain vaccines are more likely to cause these changes.
View Article and Find Full Text PDFEur J Public Health
September 2025
Real World Evidence, The Data Analytics Taskforce, European Medicines Agency, Amsterdam, The Netherlands.
The future European Health Data Space (EHDS), a network for secure cross-border data use, could be beneficial for public health initiatives. The HealthData@EU pilot project evaluated possibilities of secondary data use based on five use cases and established a pilot IT infrastructure. This article reports overarching experiences from two public health use cases and the IT development.
View Article and Find Full Text PDFMol Ther
September 2025
Sanofi, Waltham, MA, USA.
Since its use during the COVID-19 pandemic, mRNA has emerged as a leading candidate vaccine platform for pandemic infections. A critical difference between RNA-encoded antigen and protein vaccines is that RNA-based vaccines require the antigen to be translated in the body, adding an important variable. Much of the research focus in the field has been on ways to increase expression, but inflammation plays a critical role.
View Article and Find Full Text PDF